We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Demand for jabs for meningitis, diphtheria and hepatitis recovers after pandemic disruption
Brian McNamara will run business with annual sales of more than £10bn
UK drugmaker seeks to unlock £400m of private investment for site in Stevenage
Pharma group’s board backs Emma Walmsley and announces deal for brain disease drug
Activist hedge fund has outlined little more than polite introduction with air of menace
Activist fund seeks refreshed board to pick who runs UK drugmaker after consumer health spin-off
Emma Walmsley insists she is a ‘change agent’ committed to transforming pharma group
Pharma investors eager to be shot of consumer unit will retain exposure without the upsides
Walmsley has questions to answer at roadshow over direction of pharma group’s future
German drugmaker believes jab could still be used for some age groups or as booster
UK pharma group will pay iTeos Therapeutics up to $2.1bn to collaborate on a tumour drug
Head of division that sells vitamins and toothpaste reveals growth plan for soon-to-be independent business
Pharma group should keep hold of ‘crown jewel’ that has doubled profits in four years
UK group and France’s Sanofi release trial data of Covid jab showing strong immune response
Emma Walmsley says drugmaker’s pipeline shows ‘real progress’
New activist shareholder may not have quick answers to drugmaker’s underlying problems
It has quietly built up a multibillion-dollar stake in the struggling drugmaker
CEO Emma Walmsley under scrutiny as British drugmaker’s cupboard looks increasingly bare
Activist may focus on what UK drugmaker will look like after spinout of consumer heath business
Activist group’s investment comes as UK drugmaker’s performance lags behind rivals
Drugmaker will ‘fill and finish’ as-yet-unapproved jabs as talks continue over EU export controls
Moncef Slaoui forced out as chair of the board of drugmaker’s subsidiary Galvani Bioelectronics
Faith in monoclonal antibodies pays off with promising results
Data from 583 patients shows 85% reduction in hospitalisation or death
New vaccine producers and mRNA technology are shaking up the market
International Edition
